Department of Cardiac Surgery, Charles University, Faculty of Medicine and University Hospital in Hradec Králové, Czech Republic.
BIOSTER, a.s., Czech Republic.
Acta Medica (Hradec Kralove). 2022;65(2):53-58. doi: 10.14712/18059694.2022.18.
Various forms of local haemostats are increasingly used routinely in surgical procedures. Our work is the first comparison of the efficacy and safety of non-regenerated and regenerated oxidized cellulose based fibrous haemostats.
The haemostatic efficacy and safety of fibrous haemostats based on ONRC and ORC were compared in a randomized multicenter study. The primary endpoint was successful haemostasis within 3 minutes of application and no need for surgical revision within 12 hours after the procedure for recurrent bleeding.
There was a significant difference in the rate of successful haemostasis in 3 minutes that was achieved in 82% and 55% in the ONRC and ORC groups, respectively (confidence interval 99%; p = 0.009). Mean time to haemostasis was 133.9 ± 53.95 seconds and 178.0 ± 82.33 seconds, in the ONRC, and ORC group, respectively (p = 0.002). Revision surgery for re-bleeding was necessary in 0 (0%), and 1 (2%) of patients in the ONRC, and ORC group, respectively. No adverse events were reported.
Fibrous haemostat based on ONRC was non-inferior compared to fibrous haemostat based on ORC when used in accordance with its intended purpose, and was safe and efficient.
各种形式的局部止血剂在外科手术中越来越常规地使用。我们的工作首次比较了非再生和再生氧化纤维素基纤维止血剂的疗效和安全性。
在一项随机多中心研究中比较了基于 ONRC 和 ORC 的纤维止血剂的止血效果和安全性。主要终点是应用后 3 分钟内成功止血,且术后 12 小时内无需手术修正,以防止再次出血。
在 3 分钟内成功止血的比例有显著差异,ONRC 组为 82%,ORC 组为 55%(99%置信区间;p=0.009)。ONRC 组和 ORC 组的平均止血时间分别为 133.9±53.95 秒和 178.0±82.33 秒(p=0.002)。ONRC 组和 ORC 组分别有 0(0%)和 1(2%)例患者需要进行再次手术以控制再次出血。未报告不良反应。
根据其预期用途,基于 ONRC 的纤维止血剂与基于 ORC 的纤维止血剂相比是非劣效的,且安全有效。